HIV News and Research

RSS

Metabolic restoration as a therapeutic approach to promote natural immune protection against HIV

The human immunodeficiency virus (HIV-1) particularly attacks CD4 lymphocytes, a type of white blood cell considered to be the conductor of the immune system.

15 Oct 2021

New study shows how COVID-19 response has impacted the U.S. public health system

The cruel impact of COVID-19, the virus that emerged in late 2019 and has claimed 5 million lives to date, is chronicled in daily headlines. It has robbed us of loved ones, jobs, plans and so much more.

15 Oct 2021

Global progress in tackling tuberculosis has been reversed by the COVID-19 pandemic

The COVID-19 pandemic has reversed years of global progress in tackling tuberculosis and for the first time in over a decade, TB deaths have increased, according to the World Health Organization's 2021 Global TB report.

15 Oct 2021

Study detects the presence of SARS-CoV-2 in semen along with low sperm count

A new study reported findings of semen analysis from a prospective COVID-19 cohort study.

15 Oct 2021

Study reveals a detrimental role of the immune system in Lewy body dementias

T-cells respond to buildups of alpha-synuclein, the aggregated protein clumps that are a feature of neurodegenerative diseases including dementia with Lewy bodies and Parkinson's disease (PD), according to a Northwestern Medicine study published in Science.

14 Oct 2021

NIH funds new research ideas that address health disparities and advance health equity

The National Institutes of Health is funding bold, new research ideas that focus on interventions to address health disparities and advance health equity.

13 Oct 2021

Anti-rheumatic drug as a potential candidate for treating COVID-19

The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) produces inflammatory cytokine storms. But an FDA-approved anti-rheumatic drug, Auranofin, used to treat autoimmune and infectious diseases, may also help serve as an antiviral treatment for COVID-19 infection.

13 Oct 2021

New high-throughput assay could help development of anti-COVID-19 drugs

In a recent study, researchers develop a new high-throughput assay that allows for rapid screening of potential inhibitors.

13 Oct 2021

Study identifies hotspots for opioid overdose and other drug-related disorders

Combining emergency medical services and vital statistics data, a new study led by researchers from Tufts University School of Medicine provides a unique view of the opioid overdose epidemic in an urban area.

12 Oct 2021

Research reveals components of Sinbis virus ribonucleoproteins

To address this gap in research regarding the understanding of post-replicative alphavirus RNPs, scientists have created a novel proteome-wide approach known as viral RNA interactome capture (vRIC). This study is available in the bioRxiv* preprint server while awaiting peer review.

11 Oct 2021

Research finds different antibody responses following COVID vaccination and natural infection

A new study published in the journal Nature attempted to investigate memory B cell evolution 5 months after vaccination with mRNA vaccines such as Moderna (mRNA-1273) or Pfizer-BioNTech (BNT162b2) in SARS-CoV-2 naïve individuals. The study explored various aspects of memory B cell antibody response like neutralizing response, affinity, epitope targeting, and neutralizing breadth.

10 Oct 2021

Role of S-acylation in SARS-CoV-2 infectivity

A new study published in Developmental Cell investigates S-acylation of the SARS-CoV-2 S protein.

10 Oct 2021

Researchers identify new biomarker for severe COVID-19

During the pandemic, it has become increasingly evident that people with cardiovascular disease and obesity are at a much higher risk of developing very severe, even fatal COVID-19 disease.

8 Oct 2021

Study traces the evolution of hepatitis B virus since prehistoric times

A study published in the journal Science traces the evolution of the hepatitis B virus from prehistory to the present, revealing dissemination routes and changes in viral diversity. Domingo Carlos Salazar García, researcher from the Prehistory, Archeology and Ancient History Department of the University of Valencia, has participated in this study led by the Max Planck Institute for the Science of Human History (Germany).

8 Oct 2021

Adapting biological research and development to COVID-19

In this interview, News-Medical talks to Dr Yuning Chen, about the work he does with Sino Biological and how they have adapted their research & development to the COVID-19 pandemic.

From Sino Biological Inc. 8 Oct 2021

Removing high-grade squamous intraepithelial lesions reduces chances of progression to anal cancer

In a randomized clinical trial with 4,446 participants, known as the Anal Cancer/HSIL Outcomes Research (ANCHOR) study, researchers found that by removing high-grade squamous intraepithelial lesions (HSIL), chances of progression to anal cancer were significantly reduced.

8 Oct 2021

Study reveals the trends in recreational ketamine use and availability in the U.S.

Recreational ketamine use and availability of the drug have increased in recent years, but it remains an uncommon drug used by less than 1 percent of people in the U.S., according to a new study published in the American Journal of Public Health.

7 Oct 2021

Potent extended anti- SARS-CoV-2 effect of titanium dioxide surface coatings

A team of researchers has explored the possibility of coating surfaces with TiO2 as a tool to inactivate SARS-CoV-2.

7 Oct 2021

Critical function of IL-7 in diagnosis, prognosis, and treatment of COVID-19 patients

In this review, researchers summarized the therapeutic and pathogenic role of IL-7 in patients with COVID-19 and examined the promising role of IL-7 as a vaccine adjuvant.

7 Oct 2021

Pancreatic cancer clinical trials exclude Black patients based on wide range of eligibility criteria

A simulated pancreatic cancer clinical trial screening process showed that Black patients were significantly more likely than white patients to be excluded from clinical trials for a wide range of eligibility criteria, according to results presented at the virtual 14th AACR Conference on the Science of Cancer Health Disparities in Racial/Ethnic Minorities and the Medically Underserved, held October 6-8, 2021.

6 Oct 2021

HIV News and Research

Metabolic restoration as a therapeutic approach to promote natural immune protection against HIV

New study shows how COVID-19 response has impacted the U.S. public health system

Global progress in tackling tuberculosis has been reversed by the COVID-19 pandemic

Study detects the presence of SARS-CoV-2 in semen along with low sperm count

Study reveals a detrimental role of the immune system in Lewy body dementias

NIH funds new research ideas that address health disparities and advance health equity

Anti-rheumatic drug as a potential candidate for treating COVID-19

New high-throughput assay could help development of anti-COVID-19 drugs

Study identifies hotspots for opioid overdose and other drug-related disorders

Research reveals components of Sinbis virus ribonucleoproteins

Research finds different antibody responses following COVID vaccination and natural infection

Role of S-acylation in SARS-CoV-2 infectivity

Researchers identify new biomarker for severe COVID-19

Study traces the evolution of hepatitis B virus since prehistoric times

Adapting biological research and development to COVID-19

Removing high-grade squamous intraepithelial lesions reduces chances of progression to anal cancer

Study reveals the trends in recreational ketamine use and availability in the U.S.

Potent extended anti- SARS-CoV-2 effect of titanium dioxide surface coatings

Critical function of IL-7 in diagnosis, prognosis, and treatment of COVID-19 patients

Pancreatic cancer clinical trials exclude Black patients based on wide range of eligibility criteria

Shaping the Future of Neuroscience: A Conversation with Atlas Antibodies on the MolBoolean™ and the Impact of SfN 2024

How the Arts Reshape Brain Function: Susan Magsamen on the Future of Neuroaesthetics

Inside the Alzheimer's Association: Dr. Heather Snyder on Driving Research and Collaboration

Latest News